Cargando…

Observational Study of the Association of First Insulin Type in Uncontrolled Type 2 Diabetes with Macrovascular and Microvascular Disease

AIMS: To compare the risk of vascular disease, HbA1c and weight change, between first prescribed insulins in people with type 2 diabetes. METHODS: People included in THIN United Kingdom primary care record database who began insulin (2000–2007) after poor control on oral glucose-lowering agents (OGL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Gillian C., McMahon, Alex D., Carroll, Dawn, Home, Philip D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498210/ https://www.ncbi.nlm.nih.gov/pubmed/23166795 http://dx.doi.org/10.1371/journal.pone.0049908

Ejemplares similares

Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia
por: Alaboud, Aboud F., et al.
Publicado: (2016)

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses
por: Mansour, Afnan, et al.
Publicado: (2023)

Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes
por: Palladino, Raffaele, et al.
Publicado: (2020)

Endothelium in Coronary Macrovascular and Microvascular Diseases
por: Godo, Shigeo, et al.
Publicado: (2021)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
por: Sibal, Latika, et al.
Publicado: (2009)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

OR34-02 Fasting Pancreatic Polypeptide Predicts Incident Microvascular And Macrovascular Complications Of Type 2 Diabetes
por: Sam, Amir H, et al.
Publicado: (2023)

Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study
por: van Wijngaarden, Rients P. T., et al.
Publicado: (2017)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021)

Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK
por: Hall, G C, et al.
Publicado: (2013)

Impact of Specific Glucose-Control Strategies on Microvascular and Macrovascular Outcomes in 58,000 Adults With Type 2 Diabetes
por: Neugebauer, Romain, et al.
Publicado: (2013)

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
por: An, Jaejin, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases
por: Bharath, Leena P., et al.
Publicado: (2021)

Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study
por: Visaria, Jay, et al.
Publicado: (2020)

BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study
por: Polemiti, Elli, et al.
Publicado: (2021)

Relationship between Macrovascular and Microvascular Hemodynamics Assessed by Spectrophotometry in Periodontal Diseases
por: Figliuzzi, M. M., et al.
Publicado: (2021)

The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study
por: Sandoo, Aamer, et al.
Publicado: (2011)

Macrovascular complication phenotypes in type 2 diabetic patients
por: Papa, Giuseppe, et al.
Publicado: (2013)

Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease
por: Clark, Lindsay R., et al.
Publicado: (2017)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study
por: Wang, Li, et al.
Publicado: (2020)

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Association of triglyceride glucose index and triglyceride HDL ratio with glucose levels, microvascular and macrovascular complications in Diabetes Mellitus Type-2
por: Jabeen, Wajiha Mah, et al.
Publicado: (2023)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147
por: Home, Philip D.
Publicado: (2013)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Kim, Jung Hee, et al.
Publicado: (2011)

Comparisons of microvascular and macrovascular changes in aldosteronism-related hypertension and essential hypertension
por: Varano, Monica, et al.
Publicado: (2017)

Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health
por: Streese, Lukas, et al.
Publicado: (2022)

Association of a Healthy Lifestyle, Life's Essential 8 Scores With Incident Macrovascular and Microvascular Disease Among Individuals With Type 2 Diabetes
por: He, Panpan, et al.
Publicado: (2023)

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009)

Risk assessment of macrovascular and microvascular events in patients with type 2 diabetes by analyzing the amplitude variation of the fourth harmonic component of radial pulse wave
por: Liao, Kuo‐Meng, et al.
Publicado: (2019)

Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
por: Zhao, Hang, et al.
Publicado: (2019)

Increased Concentration of C-Reactive Protein in Obese Patients with Type 2 Diabetes Is Associated with Obesity and Presence of Diabetes but Not with Macrovascular and Microvascular Complications or Glycemic Control
por: Fronczyk, Aneta, et al.
Publicado: (2013)

Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis
por: Aikaeli, Faith, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hm8qcgfrmuhe2r052ea7hauuje